NICHEY

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Učitavam..

Gledati

Gledati Koluti

Događaji

Pregledajte događaje Moji događaji

Blog

Pregledajte članke

Tržište

Najnoviji proizvodi

Stranice

Moje stranice Stranice koje mi se sviđaju

Više

Forum Istražiti popularne objave Poslovi Ponude Sredstva
Koluti Gledati Događaji Tržište Blog Moje stranice Vidi sve

k kumar
k kumar  stvorio je novi članak
1 Y

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

ostalo

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics

HR+ HER2- breast cancer is the most common subtype, making up around 70% of all breast cancer cases. Characterized by hormone receptor positivity and the absence of HER2 overexpression, the prevalence of HR+ HER2- breast cancer varies globally.
Kao
Najnoviji proizvodi Vidi sve